These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6946847)

  • 41. Intensive chemotherapy of acute myelogenous leukaemia.
    Gorman A; Fennelly JJ; O'Connell LG
    J Ir Med Assoc; 1972 Oct; 65(20):509-13. PubMed ID: 4507652
    [No Abstract]   [Full Text] [Related]  

  • 42. [Our recent therapeutic experiences in acute leukemia].
    Quattrin N; Montuori R; Di Girolamo R; Cimino R
    Minerva Med; 1975 Jul; 66(51):2538-45. PubMed ID: 1057050
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute leukemia: early recognition can spell survival.
    Vaughan WP; Karp JE; Burke PJ
    Geriatrics; 1981 Jun; 36(6):32-6. PubMed ID: 6939652
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter: Chemotherapy for erythroleukemia.
    Bluming A
    N Engl J Med; 1974 Aug; 291(8):419-20. PubMed ID: 4603175
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

  • 46. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules.
    Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707
    [No Abstract]   [Full Text] [Related]  

  • 48. Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.
    Bezerra MF; Coelho-Silva JL; Nascimento JC; Benicio MT; Rocha CR; Machado CG; Rego EM; Bezerra MA; Lucena-Araujo AR; Beltrão EI
    Haematologica; 2017 Feb; 102(2):e43-e46. PubMed ID: 27846614
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

  • 50. [Steroid therapy of acute leukemia].
    Streneva TN
    Ter Arkh; 1974; 46(8):140-2. PubMed ID: 4529479
    [No Abstract]   [Full Text] [Related]  

  • 51. A 13-years remission in chronic myelocytic leukemia after a single course of busulfan.
    Weinberger A; Benjamin D; Douer D; Barabash G; Djaldetti M; Pinkhas J
    Acta Haematol; 1978; 59(6):354-9. PubMed ID: 97894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of acute non-lymphoid leukemias: comparison of two protocols.
    Hauptmann E; Stacher A; Heinz R; Jaksic B
    Osterr Z Onkol; 1977 Dec; 4(4):80-2. PubMed ID: 271937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study.
    Ohtake S; Miyawaki S; Fujita H; Kiyoi H; Shinagawa K; Usui N; Okumura H; Miyamura K; Nakaseko C; Miyazaki Y; Fujieda A; Nagai T; Yamane T; Taniwaki M; Takahashi M; Yagasaki F; Kimura Y; Asou N; Sakamaki H; Handa H; Honda S; Ohnishi K; Naoe T; Ohno R
    Blood; 2011 Feb; 117(8):2358-65. PubMed ID: 20693429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Giant mitochondria in erythroleukaemia.
    Ghadially FN; Skinnider LF
    J Pathol; 1974 Nov; 114(3):113-7. PubMed ID: 4532688
    [No Abstract]   [Full Text] [Related]  

  • 55. An unusual initial manifestation of acute leukemia.
    Desai A; Desai A; Staszewski H; Cunha BA
    Am J Med; 2012 Dec; 125(12):1173-4. PubMed ID: 23062401
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
    Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
    Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute leukaemia in adults. The experience at Royal Prince Alfred hospital, 1965-1970.
    Wilkinson T; Kronenberg H; Rickard KA
    Med J Aust; 1972 Apr; 1(16):785-8. PubMed ID: 4503392
    [No Abstract]   [Full Text] [Related]  

  • 58. Prognostic factors affecting remission, remission duration, and survival in adult acute nonlymphocytic leukemia.
    Brandman J; Bukowski RM; Greenstreet R; Hewlett JS; Hoffman GC
    Cancer; 1979 Sep; 44(3):1062-5. PubMed ID: 289433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
    Manaster J; Cowan DH; Curtis JE; Hasselback R; Bergsagel DE
    Cancer Chemother Rep; 1975; 59(3):537-45. PubMed ID: 1060509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An extreme example of focal bone marrow involvement in acute myeloid leukemia.
    Brierley CK; Morgan EA; Sprague JR; Odejide OO; DeAngelo DJ; Steensma DP
    Am J Hematol; 2013 Apr; 88(4):335-6. PubMed ID: 23115117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.